chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the COVID vaccine the client was standing with his step mother in the vaccination room while his dad was receiving a vaccine. RN noted the client's step mother instructing the client to breathe and responded. The client reported that his "eyes burning" and "nausea." The client sat down in the anti-gravity chair in a high fowler's position and was provided an emesis bag. Vitals obtained at 11:50AM were as follows: BP 110/70, HR 84, O2 97%. The client stated that immediately after receiving the vaccine he experienced blurry vision for about 2-3 minutes. The client denied any current blurry vision, headache, numbness, or shortness of breath. The client and his family members reported the client has a history of anxiety with nausea and a history of anxiety with receiving vaccines. Repeat vitals obtained at 11:50AM were as follows: BP 120/74, Hr 88, and O2 99%. The client denied any dizziness and stated he felt "normal." The client was alert and oriented to person, place, time, and situation. The client was offered water and began drinking it at 12:00PM. RN provided education to the client and his family regarding s/s of anaphylaxis, when to seek EMS, and to follow up with the client's primary care physician. The client, his father, and step-mother voiced understanding of this education. Vitals obtained at 12:10PM were as follows: BP 118/92, HR 92, O2 99%. The client denied any symptoms. The client stood up unassisted from the anti-gravity chair and ambulated unassisted out of the vaccination site at 12:15PM. VAERS completed. VAERS confirmation number.
Received flu shot approximately 11 am on 12/27/04 at 13:30 got extremely flushed and hot. Her pulse was 138, B/P was 148/92 and 100% oxygen saturation. The left side of her neck was numb feeling and flushed. She felt that she was having heart palpitations that lasted at 40 minutes at the above rate at rest, then her pulse remained around 113 until the AM. Also felt like throat getting narrow. Called health nurse, she didn't feel this was caused by injection and instructed to take tylenol.
Information has been received from a physician concerning a 14 year old female patient with drug hypersensitivity to AUGMENTIN. Who on 18-JUL-2007 was vaccinated IM into the right deltoid with a 0.5 ml first dose of Gardasil (Lot # 658222/0927U). Concomitant therapy included MENACTRA given in alternative site. The physician reported that on 19-SEP-2007, the patient developed a fever of 100F-102F, fatigue, headache off and on, mayalgia. malaise and was weak. It was reported that there was no rash or other systemic symptoms. Unspecified medical attention was sought. The patient's fever lasted for four days. Subsequently, the patient recovered from the fatigue, fever, malaise, myalgia and headache off and on and was weak.   Additional information is not expected.
Central Retinal Artery Occlusion - left eye.  There is no treatment available.  Blind in left eye.
I was positive for COVID-19 on 30DEC2023, I was at a Christmas party. the next day my ears were plugged up and felt so achy all over and throat was soar.  I Felt very tired for 2 weeks, once I felt better after 3 weeks my tongue were feeling raw. that lasting for another 2 weeks.
SCIATIC PAIN; BROKE OUT IN SWEAT; JOINT PAIN; MUSCLE PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, once a total administered, start therapy date not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sciatic pain, broke out in sweat, joint pain, and muscle pain. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from muscle pain, joint pain, and sciatic pain, and the outcome of broke out in sweat was not reported. This report was non-serious.
lost consciousness for several minutes. EMTs able to revive me. Gave IV saline. Subsequent weak and shaky episodes, Heart pounding
Right arm and neck pain-began immediately after injection, mild itching. Seen 24 hours after IZ; experiencing itching and pain; physical exam normal.
Site: Pain at Injection Site-Medium, Additional Details: patient believes it may have been injected too high on first dose. His shoulder still hurts when he raises his arm. He will monitor and get checked by md if needed and notify the pharmacy.
Pain post injection upper arm soreness; Pain post injection upper arm soreness; This is a spontaneous report from contactable nurse via Pfizer Sales Representative. A patient of unknown age and gender received on an unknown date a single dose of pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) in the arm for immunization. Medical history and concomitant medications were not reported. The patient had pain post injection, upper arm soreness. Outcome was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Syringe broke; Full dose immediately in other arm; This spontaneous case was reported by a physician and describes the occurrence of SYRINGE ISSUE (Syringe broke) and ACCIDENTAL OVERDOSE (Full dose immediately in other arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SYRINGE ISSUE (Syringe broke) and ACCIDENTAL OVERDOSE (Full dose immediately in other arm). At the time of the report, SYRINGE ISSUE (Syringe broke) and ACCIDENTAL OVERDOSE (Full dose immediately in other arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  This report refers to a case of syringe issue and accidental overdose for mRNA-1273, lot # 029A21A with no associated AEs.; Sender's Comments: This report refers to a case of syringe issue and accidental overdose for mRNA-1273, lot # 029A21A with no associated AEs.
Error dose given.  Patient already got two shingrix shots 2019 and 2020.  She was given an additional dose 7/25/2022.  No adverse even reported from patient.
Patient reported pain at time of injection. Later reported redness, swelling, hot to touch, stinging, itching, and hardness in places.
This spontaneous report was received from a registered nurse, and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, previous drug reactions, allergies, concurrent conditions or concomitant medications. It was reported that on 06-DEC-2018, the patient received an improperly stored dose of PROQUAD (Lot # R012416 and expiration date 28-OCT-2019), subcutaneously (dose and anatomical location were not reported) for prophylaxis. The dose of PROQUAD was exposed to a temperature excursion of 11.9 Fahrenheit (F) during a timeframe of 117 hours, which was detected by a digital data logger. The vaccine was reconstituted with properly stored sterile diluent. There were no previous temperature excursions. No adverse event. This is one of seven reports received from the same reporter. Sender's Comments: US-009507513-1903USA001826: US-009507513-1903USA002595: US-009507513-1903USA002597: US-009507513-1903USA002598: US-009507513-1903USA002599: US-009507513-1903USA002600.
Had pain at the injection site. Numbness at the numbness site. Diagnosed with deltoide appendicitis- started in my left foot. Spot on right thigh that has increasing pain. Left rib has a spotted that feels irritated. Have had a cough since vaccination.
got shingles but take shot/suspected vaccination failure; got shingles; hurt; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got shingles but take shot/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: got shingles) and pain (Verbatim: hurt). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 24-Mar-2023 The case was received from the patient via interactive digital media. The patient stated that what he or she got shingles but he or she did took the shot and so hurt. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Tried to get out of bed about 11:00 pm, was terribly dizzy. Got back in bed, went back to sleep. Woke up at 8 am and called my boyfriend to take me to the ER, I was so dizzy couldn't open my eyes and was vomiting. Er Dr. said I had Vertigo and sent me home with Meclazine, and one other med, can't remember the name. I went to my medical dr. on the following tuesday and he sent me to a therapist that treats vertigo. I had three treatments that helped some, so that I could go back to work. Then this past Friday evening the 6th of January, it came back. Nothing open to treat me this weekend, so waiting to get into an ENT tomorrow.
redness; 2 inch x 5 inch raised up to 1cm in the center; Irregular Itching; Soreness in arm; A spontaneous report was received from a Health care professional concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Soreness in arm, 2 inch x 5 inch raised up to 1cm in the center,  and Redness.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 14 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 via Intramuscular route for prophylaxis of COVID-19 infection.  On 14 Jan 2021, the patient experienced the event Soreness in arm. On 24 Jan 2021, the patient experienced the event 2 inch x 5 inch raised up to 1cm in the center, and Redness. The Patient was treated with Benadryl (25 mg).  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events Soreness in arm, 2 inch x 5 inch raised up to 1cm in the center and Redness was Not Recovered/Not Resolved.
No adverse event; Patient received Moderna Covid-19 Bivalent vaccine vaccine past the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent vaccine vaccine past the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7162B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent vaccine vaccine past the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent vaccine vaccine past the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent vaccine vaccine past the 30 day beyond use date).    No concomitant medications were reported.  The vaccine was delivered to the hospital on 20-Sep-2022.  No treatment medications were reported.  This case contains information for the 4th of 9th adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-725025 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-725025:Master case
Numbness in hands/face immediately following vaccine. Constant numbness in right thumb that continues to this day; numbness/tingling in hands/fingers that comes and goes
Moderna Vaccine expired 10/20/2021 at 0600 at refrigerator temperature. Vaccine administered approximately 5 hours after expiration time on 10/20/2021. Moderna Manufacturing company consulted and stated: It is recommended that the vaccine be used by 30 days to the expiration date and time; however, it is ok to use by the end of the day on the 30th day. No treatment required.
3 February 2021@1130-Today-HA, itchy upper body, rt deltoid area swollen-she said  Reminded to go to the ER if her symptoms get worse-call her PCM also
LPN inadvertently administered a higher-than-authorized dose volume (1 mL administered instead of 0.5 mL) of Moderna. This was the recipient's first vaccine dose of the Moderna series. The recipient was informed of the administration error and counseled per  "Interim recommendations for COVID-19 vaccine administration errors and deviations." The recipient denies any local or systemic side effects following vaccination at this time. Will follow-up with recipient daily for the next 2 days. Recipient has name/number of who to contact at if any questions/concerns.
pt recv vax 27FEB97 & states awakened on 28FEB97 & felt sore all over;inj site was hot & swollen;as day progressed, noted body rash & low grade fever 99.6;felt like everything was swollen inside-pt w/bowels & bladder;
Arm pain that's still hurting til this day. Back pain. Can not raise arm. Shoulder hurts also.
Redness and swelling ~1 inch in diameter, ~1 inch to the left of injection site. Moderate pain for the first day, mild pain on the second and third day.   Muscle pain in neck and shoulders, mild on first day Mild fatigue days 1-3
the vaccination site arm muscle at first dose hurt; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  An 80 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in arm (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "the vaccination site arm muscle at first dose hurt".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm discomfort; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm discomfort) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) and CIPROFLOXACIN for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (arm discomfort). At the time of the report, LIMB DISCOMFORT (arm discomfort) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     No treatment medication information was provided.
Within 8 hours of the first dose I experience GI issues loss of appetite lasting about 5 days.; Within 8 hours of the first dose I experience GI issues loss of appetite lasting about 5 days.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 14:00 (Lot number: ER8732) at the age of 36 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Some chronic GI issues, nothing formally diagnosed." (unspecified if ongoing). The patient took concomitant medications. The following information was reported: GASTROINTESTINAL DISORDER (non-serious), DECREASED APPETITE (non-serious), outcome "recovering" and all described as "Within 8 hours of the first dose I experience GI issues loss of appetite lasting about 5 days.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of gastrointestinal disorder, decreased appetite.  Additional Information: Facility type vaccine was doctor's office/urgent care. No other vaccine in four weeks. Patient taken other medications in two weeks. Adverse event within 8 hours of the first dose patient experience gastrointestinal issues loss of appetite lasting about 5 days. Within 6 days of the 2nd dose i experienced gastrointestinal issues lasting 4 days and still ongoing. also, have experience an unusual smell (off and on) during the same time frame. No covid prior vaccination. Patient tested covid post vaccination. Covid test post vaccination done by covid test type reported as nasal swab, covid test date conducted on 09may2021 and covid test result were negative. No known allergies. Other medical history reported as some chronic gastrointestinal issues, nothing formally diagnosed.  No follow-up attempts are possible. No further information is expected.
11/13/09 Broke-out in rash/chest/neck-on next day (11/14). Breaking out each day since. Macular rash-"red dots".
I have had muscle cramps,  fevers, fatigue, headache, cough, shortness of breath ,  aches and pains whole body, stomach pain, nausea, unable to sleep long periods. Taste and smell issues, itchy hives, swollen itchy eyes, swollen lower extremities.
DIARRHEA. RED BUMPS NEAR INJECTION SITE INITIALLY THEN SWELLING NEAR INJECTION SITE WITHIN THE SAME DAY. OVER THE NEXT TWO DAYS, LIPS STARTED SWELLING, HIVES ON THE FACE, ITCHY SCALP, TROUBLE BREATHING (USING INHALER MORE FREQUENTLY).
Fever, body ache, headache, fatigue.  Started the day after I took the vaccine, symptoms subsided the second day but returned the third day.
vomited; Body aches; fever; severe headache; fatigue; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Arm Left on 17Feb2021 09:30 (Batch/Lot Number: EL3247) as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in Arm Left on 28Jan2021 11:15 (Batch/Lot Number: EL3247) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Not known allergies. On 17Feb2021 19:00 PM patient experienced Fever 38.5 starting 10 hours after injection, lasting 16 hours, went down to 37.5 after taking Tylenol. Body aches, severe headache, vomited once. Now is 48 hours after injection temperature is normal, there is some fatigue. The patient was not received any treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
achy and feverish the next day only: redness, itchy and slightly swelling around the injection site for at least four days afterward
Starting in 12/2021, I was feeling dizzy, having muscle cramps and I was having a hard time keeping my balance. I went to the ER and they told me I had gone from stage 3 to stage 4 Kidney Disease. They gave me IV fluids and tried to flush them out. They gave me a run of antibiotics due to the kidneys showing infection.
Information has been received from a medical assistant concerning a 57 year old female patient with osteopenia, gastro esophageal reflux disease, chronic obstructive pulmonary disease, depression, chronic pain syndrome and hyperlipidemia who on 20-APR-2011 was vaccinated with a dose of PNEUMOVAX 23 (dose and route not reported) (Lot number 669382/1490z). Concomitant therapy included ezetimibe (MSD), pravastatin Na, SPIRIVA, NEXIUM, CYMBALTA, ATIVAN, TOPAMAX, oxycodone and OXYCONTIN. The medical assistant reported that on 20-APR-2011 the patient experienced a fever of 100.7 and complained of chills, pain in the arm where she received the injection and reduced mobility in that arm. The patient had difficult sleeping the previous night and she said that he normal pain medications did not give her relief. Laboratory diagnostics studies were not performed. The patient presented at the office on 21-APR-2011. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Developed fevers, chills, cold sweats, rapid heart beat, and shortness of breath approx 6:30 pm after 11 am vaccination.  Admitted to hospital for 5 days.  Cultures negative.  Dx at discharge COPD exacerbation
Infant began having seizure-like episode upon waking, every time she woke from deep sleep. We saw the pediatrician about this and they then referred us to hospital. We also saw an ND, HmD, PhD several times. Patient received PT for motor delays and now is receiving speech therapy for language delays.
Hepatitis A given in error as child is 9 months old.  Should have received Hepatitis B Per Dr. no adverse reaction expected.  Parents notified